Submit Deal

Kenji Yasukawa

Chairman at ASTELLAS PHARMA INC

Manager

Deal Bio

Total Deals6

Valued Deals6

Total Value£3,323M

Avg. Deal Size£554M

Market Context

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

Expertise

Key Relationships (6)

Sort

United States

Biotechnology

PrivateAcquisition

target

Potenza Therapeutics

bidder

Astellas Pharma

£177m

3 dealmakers

United States

Biotechnology

AcquisitionPublicMajority

target

Audentes Therapeutics

bidder

Astellas Pharma

£2,318m

73 dealmakers

United States

Biotechnology

AcquisitionMajorityPrivate

target

Xyphos Biosciences

bidder

Astellas Pharma

£509m

2 dealmakers

United States

Biotechnology

MergerCross BorderMajorityAcquisitionPrivatePrivate Equity

target

Iota Biosciences

bidder

Astellas Pharma

£97m

6 dealmakers

Japan

Pharmaceuticals

AcquisitionCross BorderMajorityPrivate

target

Products Rights For Five Legacy Products

bidder

Cheplapharm Arzneimittel Gbmh

£81m

5 dealmakers

United States

Pharmaceuticals

Cross BorderPrivateAcquisitionMajority

target

Propella Therapeutics

bidder

Astellas Pharma

£137m

41 dealmakers

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy